$44.31
2.19%
NYSE, Jul 11, 10:00 pm CET
ISIN
BMG3922B1072
Symbol
G

Genpact Limited Target price 2025 - Analyst rating & recommendation

Genpact Limited Classifications & Recommendation:

Buy
59%
Hold
41%

Genpact Limited Price Target

Target Price $51.00
Price $44.31
Potential
Number of Estimates 13
13 Analysts have issued a price target Genpact Limited 2026 . The average Genpact Limited target price is $51.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 17 analysts: 10 Analysts recommend Genpact Limited to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Genpact Limited stock has an average upside potential 2026 of . Most analysts recommend the Genpact Limited stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 4.77 5.06
6.48% 6.14%
EBITDA Margin 15.28% 18.01%
3.94% 17.85%
Net Margin 10.78% 12.24%
23.58% 13.59%

14 Analysts have issued a sales forecast Genpact Limited 2025 . The average Genpact Limited sales estimate is

$5.1b
Unlock
. This is
4.31% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.3b 8.37%
Unlock
, the lowest is
$4.8b 0.41%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $4.8b 6.48%
2025
$5.1b 6.14%
Unlock
2026
$5.4b 6.26%
Unlock
2027
$5.8b 8.18%
Unlock

10 Analysts have issued an Genpact Limited EBITDA forecast 2025. The average Genpact Limited EBITDA estimate is

$911m
Unlock
. This is
21.56% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$975m 30.06%
Unlock
, the lowest is
$806m 7.46%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $729m 10.68%
2025
$911m 25.08%
Unlock
2026
$1.0b 10.18%
Unlock
2027
$1.1b 7.67%
Unlock

EBITDA Margin

2024 15.28% 3.94%
2025
18.01% 17.85%
Unlock
2026
18.67% 3.66%
Unlock
2027
18.58% 0.48%
Unlock

13 Genpact Limited Analysts have issued a net profit forecast 2025. The average Genpact Limited net profit estimate is

$619m
Unlock
. This is
17.39% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$643m 21.85%
Unlock
, the lowest is
$590m 11.74%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $514m 18.63%
2025
$619m 20.57%
Unlock
2026
$677m 9.28%
Unlock
2027
$755m 11.54%
Unlock

Net Margin

2024 10.78% 23.58%
2025
12.24% 13.59%
Unlock
2026
12.59% 2.86%
Unlock
2027
12.98% 3.10%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 2.85 3.54
16.42% 24.21%
P/E 12.51
EV/Sales 1.66

13 Analysts have issued a Genpact Limited forecast for earnings per share. The average Genpact Limited EPS is

$3.54
Unlock
. This is
20.41% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$3.68 25.17%
Unlock
, the lowest is
$3.37 14.63%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $2.85 16.42%
2025
$3.54 24.21%
Unlock
2026
$3.87 9.32%
Unlock
2027
$4.32 11.63%
Unlock

P/E ratio

Current 15.07 73.77%
2025
12.51 17.00%
Unlock
2026
11.45 8.47%
Unlock
2027
10.26 10.39%
Unlock

Based on analysts' sales estimates for 2025, the Genpact Limited stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.74 26.09%
2025
1.66 4.36%
Unlock
2026
1.57 5.90%
Unlock
2027
1.45 7.57%
Unlock

P/S ratio

Current 1.60 31.19%
2025
1.53 4.13%
Unlock
2026
1.44 5.90%
Unlock
2027
1.33 7.56%
Unlock

Current Genpact Limited Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Mizuho
Locked
Locked
Locked Jul 01 2025
Needham
Locked
Locked
Locked Jun 30 2025
Baird
Locked
Locked
Locked May 08 2025
Needham
Locked
Locked
Locked May 08 2025
Mizuho
Locked
Locked
Locked Feb 10 2025
Needham
Locked
Locked
Locked Feb 07 2025
Jefferies
Locked
Locked
Locked Jan 21 2025
Analyst Rating Date
Locked
Mizuho:
Locked
Locked
Jul 01 2025
Locked
Needham:
Locked
Locked
Jun 30 2025
Locked
Baird:
Locked
Locked
May 08 2025
Locked
Needham:
Locked
Locked
May 08 2025
Locked
Mizuho:
Locked
Locked
Feb 10 2025
Locked
Needham:
Locked
Locked
Feb 07 2025
Locked
Jefferies:
Locked
Locked
Jan 21 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today